Jennifer Lawrence has signed up to play Elizabeth Holmes in an upcoming film about medical company Theranos.
The project, set to be produced by Adam McKay (the man behind recent hit film The Big Short) focuses on the rise and fall of Holmes, who set the stock exchange alight with Theranos – a company that was set to revolutionise medicine.
Founded by Holmes in 2003, Theranos’s much-hyped blood testing system claimed that it could perform tests using only a pinprick of blood, as opposed to the current method of extracting blood via syringe.
Its commercial potential resulted in its high share value, at one point being worth over $9 billion. Holmes, who owned 50% of the company, was ranked by Forbes as America's richest self-made woman, herself worth an estimated $4.5 billion.
However, an expose by the Wall Street Journal found that some of the company’s claims were inaccurate, and Theranos is now under investigation by federal law to determine whether investors were intentionally deceived.
Whilst Holmes, a one-time winner of Glamour magazine’s Entrepreneur Award, disputed these claims, this did not stop the stock prices for Theranos plummeting, leaving Holmes with a net-worth of next to nothing.
With a slew of major awards to her name already, Jennifer Lawrence has firmly established herself as one of Hollywood's most bankable - and endearing - leading ladies. She'll star opposite Chris Pratt in sci-fi drama Passengers later this year, and it's been rumoured that she'll star in a new all-female re-boot of Ocean's Eleven. Not bad...
READ MORE: This Beauty Product Got In The Way Of Jennifer Lawrence's Last Relationship
READ MORE: Jennifer Lawrence Thinks Hollywood Needs A 'New Normal' Body Type